The source of CAR-T cells can be either from the same patients (autologous) or from other donor (allogeneics). The allogeneic T cells have wide availability but it is more likely to cause immune rejection. https://t.co/bnLKWUMUu2(Darel Martínez et al., 202
0 followers
847 followers
Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma https://t.co/yuZBjU5A8S
2,332 followers
RT @MiglioriniDenis: Check out our review in Front. Immunol. about #Allogeneic #CART cells in the clinical setting of primary brain tumors…
2,332 followers
RT @BLLPHD: Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma by former @PennMedicine col…